bpc 157 with tirzepatide isn't a weight drug. It's an inflammation drug that happens to help weight. That's why it's quietly changing the MCAS conversation. Dual GLP-1 / GIP agonist. GLP-1 slows gut motility bpc 157 with tirzepatide BPC-157

In some embodiments, the otic formulation or composition comprises between about 0.01% to about 30% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof

Nguyen-Powanda P, Robaire B

A typical protocol involves daily or near-daily subcutaneous injections during an active cycle, followed by a transition to oral NMN supplementation (typically 250 to 500 mg/day) during the maintenance phase

Post-cycle / axis restart higher and time-limited

He firmly believes in educating the patient about the importance of good nutrition, hormone balance, stress management, and regular exercise is the key to aging well and having a high quality of life well into your golden years.